Digital Health Platform Avegen operates a scalable digital health platform, HealthMachine, offering customizable digital health solutions and digitised clinical workflows. This presents a sales opportunity to upsell bespoke digital therapeutics and workflow integrations to hospitals, pharma partners, research institutes, and healthcare providers seeking scalable, compliant digital health tools.

AI-Driven Care Recent launch of an AI-powered recommendation engine within TfH indicates competence in applying AI to personalize care and improve outcomes. This creates a chance to position advanced AI capabilities for risk stratification, personalized patient journeys, and bias-checked decision support with potential health economics benefits.

Longitudinal Reach Products touch over 2 million patients across infectious diseases, cardiovascular/metabolics, oncology, endocrinology, mental health, and maternal health. This broad exposure signals opportunities to cross-sell modules across conditions, expand into new therapeutic areas, and partner with payers or providers aiming for disease-area digital transformation.

Enterprise Readiness Tech stack includes cloud-based data services and analytics (BigQuery, RDS) and modern development practices, suggesting readiness for enterprise-scale deployments, data integration, and secure, compliant data workflows. Target larger health systems or research networks that require robust data governance and scalable implementation.

Growth Signals Revenue in the multi-million range with a growing partner ecosystem and a focus on collaboration with pharmaceutical companies and research institutes. This points to opportunities in expanding partner programs, joint development with life sciences customers, and pursuing larger contract values through expanded HealthMachine deployments.